Top compounds associated with response to OR2V1


Feature Type Standardized
Nominal ANOVA
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.033 0.5
mRNA BRD-K96431673 CTRPv2 pan-cancer AAC 0.045 0.5
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA PX-12 CTRPv2 pan-cancer AAC -0.018 0.5
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.021 0.5
mRNA BRD-K02492147 CTRPv2 pan-cancer AAC -0.025 0.5
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.023 0.5
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.026 0.5
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA darinaparsin CTRPv2 pan-cancer AAC -0.031 0.5
Download CSV